Market Intelligence chevron_right Medical Care chevron_right DNA Analysis in Government Market In Global
Global Report 2022

DNA Analysis in Government Market, Global Outlook and Forecast 2024-2031

calendar_todayPublished: Feb 2022 descriptionPages: 69 categoryCategory: Medical Care

This report contains market size and forecasts of DNA Analysis in Government in Global, including the following market information:
Global DNA Analysis in Government Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global DNA Analysis in Government market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Equipment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of DNA Analysis in Government include Roche, Thermo Fisher Scientific, Illumina, Agilent Technologies, Laboratory Corporation, Promega, GE Healthcare, QIAGEN and LGC Forensics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the DNA Analysis in Government companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global DNA Analysis in Government Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global DNA Analysis in Government Market Segment Percentages, by Type, 2021 (%)
Equipment
Supplies
Global DNA Analysis in Government Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global DNA Analysis in Government Market Segment Percentages, by Application, 2021 (%)
Forensics
Law Enforcement
Global DNA Analysis in Government Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global DNA Analysis in Government Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies DNA Analysis in Government revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies DNA Analysis in Government revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Thermo Fisher Scientific
Illumina
Agilent Technologies
Laboratory Corporation
Promega
GE Healthcare
QIAGEN
LGC Forensics
Morpho (Safran)
NEC
ZyGEM
Applied DNA Sciences Inc

Frequently Asked Questions

What is the USP of the report? expand_more
DNA Analysis in Government Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
DNA Analysis in Government Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
DNA Analysis in Government Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.